Cardiometabolic Devices Accuracy Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 359 participants.

Also called NCT05257564

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 359 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05257564
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Nepal (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05257564. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-02-14 (actual); primary completion 2022-05-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cardiometabolic Devices Accuracy Study
Condition
Diabetes Mellitus
Condition
Chronic Kidney Diseases
Condition
Hyperlipidemias
Intervention (Device)
Determine the accuracy of quantitative measurements of GLU, HbA1c (A1C),CHOL and CRE with POC devices compared to a laboratory reference method (Roche)
Lead sponsor
Foundation for Innovative New Diagnostics, Switzerland (class: other)
Collaborator
University Hospital, Geneva (class: other)
Collaborator
B.P. Koirala Institute of Health Sciences (class: other)

Record details

Record id
cardio:ct-nct05257564
Content hash
9eb0a0524a529344d5a1eb36760e4258ae207c23934149eeb05e098664594a22